Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Five Botulinum Toxin Type A Products for Glabellar Rhytides
NCT06448676Phase 4Recruiting
- Sponsor
- University of Amsterdam
- Start
- Feb 2026
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in glabellar rhytides, sponsored by University of Amsterdam. Started Feb 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT06448676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06448676.